Cargando…
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada
BACKGROUND: Cholinesterase inhibitors are used to treat the symptoms of dementia and can theoretically cause bradycardia. Previous studies suggest that patients taking these medications have an increased risk of undergoing pacemaker insertion. Since these drugs have a marginal impact on patient outc...
Autores principales: | Huang, Allen R, Redpath, Calum J, van Walraven, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419497/ https://www.ncbi.nlm.nih.gov/pubmed/25927641 http://dx.doi.org/10.1186/s12883-015-0325-1 |
Ejemplares similares
-
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada
por: Ali, Thibault B., et al.
Publicado: (2015) -
Describing the linkage between administrative social assistance and health care databases in Ontario, Canada
por: de Oliveira, Claire, et al.
Publicado: (2022) -
Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
por: Hoffmann, Falk, et al.
Publicado: (2011) -
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
por: Balázs, Nóra, et al.
Publicado: (2021) -
The utility of administrative data for neurotrauma surveillance and prevention in Ontario, Canada
por: Parsons, Daria, et al.
Publicado: (2012)